{"id":46275,"date":"2022-11-10T14:13:32","date_gmt":"2022-11-10T12:13:32","guid":{"rendered":"https:\/\/newserver.fyb.de\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/"},"modified":"2022-11-10T14:13:32","modified_gmt":"2022-11-10T12:13:32","slug":"pre-series-a-over-e10-million-for-dementia-detection-app-neotiv","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/","title":{"rendered":"Pre-Series A over \u20ac10 million for dementia detection APP neotiv"},"content":{"rendered":"<p><strong> <\/strong><strong>Magdeburg\/ Zurich \u2014 <\/strong>Conver\u00adgence Part\u00adners parti\u00adci\u00adpa\u00adtes in a signi\u00adfi\u00adcantly over\u00adsub\u00adscri\u00adbed Pre-Series A finan\u00adcing round for digi\u00adtal health company neotiv GmbH. The total volume is EUR 10 million. Co-inves\u00adtors in this round include Capri\u00adcorn Part\u00adners, High-Tech Gr\u00fcn\u00adder\u00adfonds, bmp Ventures, RSJ Fonds, Sana Future GmbH and Vega Venture. The Magde\u00adburg-based startup has deve\u00adlo\u00adped an app that can be used to diagnose demen\u00adtia dise\u00ada\u00adses at an early stage.<strong> <\/strong><\/p>\n<p><strong>Detect Alzhei\u00admer\u2019s dise\u00adase earlier<\/strong><\/p>\n<p>With the CE-marked medi\u00adcal device neotiv\u00adCare\u00ae, neotiv offers digi\u00adtal memory tests for people with self-percei\u00adved memory problems and supports the diagno\u00adsis of mild cogni\u00adtive impair\u00adment (MCI). Dr. Chris Rehse, CEO and neotiv co-foun\u00adder explains: \u201cThe number of pati\u00adents, physi\u00adci\u00adans and health insu\u00adr\u00aders who are relia\u00adbly supported in the diagno\u00adsis of \u2018mild cogni\u00adtive impair\u00adment (MCI)\u2019 through the use of our revo\u00adlu\u00adtio\u00adnary medi\u00adcal product neotiv\u00adCare\u00ae is growing rapidly. Only compre\u00adhen\u00adsive care with relia\u00adble diagno\u00adses will set the course for inno\u00adva\u00adtive thera\u00adpies for early Alzhei\u00admer\u2019s dise\u00adase, which is often unde\u00adtec\u00adted, and can thus help many people affec\u00adted.\u201d<strong> <\/strong><\/p>\n<p><strong>Signi\u00adfi\u00adcantly increase treat\u00adment chances<\/strong><\/p>\n<p>The company was foun\u00added five years ago. Using the unique neotiv\u00adCare\u00ae app, pati\u00adents test the memory func\u00adtions of speci\u00adfic brain regi\u00adons asso\u00adcia\u00adted with the early deve\u00adlo\u00adp\u00admen\u00adtal stages of demen\u00adtia over an exten\u00added period of time. Thus, neotiv\u00adCare\u00ae can relia\u00adbly detect the effects of Alzhei\u00admer\u2019s patho\u00adlogy before symptoms are visi\u00adble. The earlier a diagno\u00adsis is made, the faster and more effec\u00adtive treat\u00adment can be initia\u00adted. \u201cThe tech\u00adno\u00adlo\u00adgi\u00adcal foun\u00adda\u00adtion we have crea\u00adted with neotiv\u00adCare\u00ae allows all physi\u00adci\u00adans to relia\u00adbly inves\u00adti\u00adgate suspec\u00adted cases of MCI against a back\u00addrop of rising preva\u00adlen\u00adces. This puts us in a unique posi\u00adtion to rapidly deli\u00adver dise\u00adase-modi\u00adfy\u00ading drugs to pati\u00adents,\u201d says Prof. Emrah D\u00fczel, Chief Medi\u00adcal Offi\u00adcer and co-foun\u00adder, describ\u00ading neoti\u00adv\u2019s contri\u00adbu\u00adtion to the stan\u00addard care of the future.<\/p>\n<p><strong>Coope\u00adra\u00adtion with health insu\u00adrance companies<\/strong><\/p>\n<p>Neotiv has alre\u00adady agreed coope\u00adra\u00adti\u00adons with health insu\u00adr\u00aders, and further talks are curr\u00adently under\u00adway. Accor\u00adding to an esti\u00admate by the German Alzhei\u00admer Society, 1.8 million people have Alzhei\u00admer\u2019s dise\u00adase. Last year alone, 440,000 people were added to the work\u00adforce in Germany. Accor\u00adding to the World Alzhei\u00admer Report of 2021, only 40% of pati\u00adents receive a diagno\u00adsis. \u201cThe deve\u00adlo\u00adp\u00adment of powerful drugs to treat Alzhei\u00admer\u2019s is on the verge of a breakth\u00adrough follo\u00adwing recent posi\u00adtive news from ongo\u00ading clini\u00adcal trials. But all of these thera\u00adpeu\u00adtics rely on detec\u00adting the dise\u00adase early. This is where neoti\u00adv\u2019s revo\u00adlu\u00adtio\u00adnary diagno\u00adstics make a crucial contri\u00adbu\u00adtion to comba\u00adting the wide\u00adspread dise\u00adase of the 21st century,\u201d explains Daniel Koppel\u00adkamm, Mana\u00adging Part\u00adner of Conver\u00adgence Partners.<\/p>\n<p><strong>About neotiv GmbH<\/strong><\/p>\n<p>neotiv GmbH is a spin-off of the OVGU Magde\u00adburg in close coope\u00adra\u00adtion with the German Center for Neuro\u00adde\u00adge\u00adnera\u00adtive Dise\u00ada\u00adses \u2014 DZNE. neotiv GmbH was foun\u00added in 2014 and is head\u00adquar\u00adte\u00adred in Magde\u00adburg with an addi\u00adtio\u00adnal office in Berlin. The goal of the young company is to trans\u00adlate the latest findings in neuro\u00adsci\u00adence into products that can be used in science and in the health\u00adcare system. The focus here is on mobile apps for smart\u00adphones and tablets that enable test\u00ading of important memory func\u00adtions. Further, health system bene\u00adfits are a core appli\u00adca\u00adtion area. The medi\u00adcal device neotiv\u00adCare supports pati\u00adents in the medi\u00adcal assess\u00adment of self-percei\u00adved memory problems. Tests can be perfor\u00admed in the home envi\u00adron\u00adment, which are later evalua\u00adted with the doctor and help to iden\u00adtify a possi\u00adble dise\u00adase, such as Alzhei\u00admer\u2019s, at an early stage. In order to be able to inte\u00adgrate such appli\u00adca\u00adti\u00adons into the health\u00adcare system in a scien\u00adti\u00adfi\u00adcally valid and sustainable way, neotiv actively coope\u00adra\u00adtes with various inter\u00adna\u00adtio\u00adnal studies and important insti\u00adtu\u00adti\u00adons of the health\u00adcare system.  <a href=\"https:\/\/neotiv.com\/en\">https:\/\/neotiv.com\/en<\/a><\/p>\n<p><strong>About Conver\u00adgence Part\u00adners&nbsp;AG<\/strong><br>\nConver\u00adgence Part\u00adners AG (\u201cConver\u00adgence\u201d) is a Swiss Health\u00adTech venture capi\u00adtal firm actively support\u00ading the inter\u00adna\u00adtio\u00adna\u00adliza\u00adtion of its port\u00adfo\u00adlio compa\u00adnies in the four largest health\u00adcare markets USA, China, India and Germany. Conver\u00adgence has offices in Switz\u00ader\u00adland, Germany, Spain and Hong Kong and was foun\u00added in 2018 by expe\u00adri\u00aden\u00adced health\u00adcare indus\u00adtry play\u00aders and venture capi\u00adta\u00adlists with the goal of connec\u00adting EU Health\u00adTech inno\u00adva\u00adtions with large inter\u00adna\u00adtio\u00adnal scale-up and exit poten\u00adtial. Conver\u00adgence focu\u00adses on later-stage invest\u00adments in digi\u00adtal health, medi\u00adcal devices and diagno\u00adstics. Current key invest\u00adment areas include Mental Health, Women\u2019s Health and Compu\u00adta\u00adtio\u00adnal Biology. Conver\u00adgence is the venture capi\u00adtal part\u00adner of \u201cMedi\u00adcal Valley\u201d in Nurem\u00adberg-Erlan\u00adgen, Germany\u2019s \u201cDigi\u00adtal Health Center of Excel\u00adlence\u201d. https:\/\/www.convergence-partners.ch\/home .<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Magdeburg\/ Zurich \u2014 Conver\u00adgence Part\u00adners parti\u00adci\u00adpa\u00adtes in a signi\u00adfi\u00adcantly over\u00adsub\u00adscri\u00adbed Pre-Series A finan\u00adcing round for digi\u00adtal health company neotiv GmbH. The total volume is EUR 10 million. Co-inves\u00ad\u00adtors in this round include Capri\u00adcorn Part\u00adners, High-Tech Gr\u00fcn\u00adder\u00adfonds, bmp Ventures, RSJ Fonds, Sana Future GmbH and Vega Venture. The Magde\u00ad\u00adburg-based startup has deve\u00adlo\u00adped an app that&nbsp;can&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":46272,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1369,1373],"tags":[],"class_list":["post-46275","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-investors","category-venture-capital-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pre-Series A over \u20ac10 million for dementia detection APP neotiv - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pre-Series A over \u20ac10 million for dementia detection APP neotiv - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Magdeburg\/ Zurich \u2014 Conver\u00adgence Part\u00adners parti\u00adci\u00adpa\u00adtes in a signi\u00adfi\u00adcantly over\u00adsub\u00adscri\u00adbed Pre-Series A finan\u00adcing round for digi\u00adtal health company neotiv GmbH. The total volume is EUR 10 million. Co-inves\u00adtors in this round include Capri\u00adcorn Part\u00adners, High-Tech Gr\u00fcn\u00adder\u00adfonds, bmp Ventures, RSJ Fonds, Sana Future GmbH and Vega Venture. The Magde\u00adburg-based startup has deve\u00adlo\u00adped an app that can [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-10T12:13:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Pre-Series A over \u20ac10 million for dementia detection APP neotiv\",\"datePublished\":\"2022-11-10T12:13:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/\"},\"wordCount\":718,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Investors\",\"Venture Capital\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/\",\"url\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/\",\"name\":\"Pre-Series A over \u20ac10 million for dementia detection APP neotiv - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg\",\"datePublished\":\"2022-11-10T12:13:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg\",\"width\":2048,\"height\":1350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pre-Series A over \u20ac10 million for dementia detection APP neotiv\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pre-Series A over \u20ac10 million for dementia detection APP neotiv - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/","og_locale":"en_US","og_type":"article","og_title":"Pre-Series A over \u20ac10 million for dementia detection APP neotiv - FYB Financial Yearbook","og_description":"Magdeburg\/ Zurich \u2014 Conver\u00adgence Part\u00adners parti\u00adci\u00adpa\u00adtes in a signi\u00adfi\u00adcantly over\u00adsub\u00adscri\u00adbed Pre-Series A finan\u00adcing round for digi\u00adtal health company neotiv GmbH. The total volume is EUR 10 million. Co-inves\u00adtors in this round include Capri\u00adcorn Part\u00adners, High-Tech Gr\u00fcn\u00adder\u00adfonds, bmp Ventures, RSJ Fonds, Sana Future GmbH and Vega Venture. The Magde\u00adburg-based startup has deve\u00adlo\u00adped an app that can [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2022-11-10T12:13:32+00:00","og_image":[{"width":2048,"height":1350,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Pre-Series A over \u20ac10 million for dementia detection APP neotiv","datePublished":"2022-11-10T12:13:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/"},"wordCount":718,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg","articleSection":["General","Featured","News","Investors","Venture Capital"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/","url":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/","name":"Pre-Series A over \u20ac10 million for dementia detection APP neotiv - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg","datePublished":"2022-11-10T12:13:32+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2022\/11\/aw-dzv8s-2-scaled.jpeg","width":2048,"height":1350},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/pre-series-a-over-e10-million-for-dementia-detection-app-neotiv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Pre-Series A over \u20ac10 million for dementia detection APP neotiv"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/46275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=46275"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/46275\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/46272"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=46275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=46275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=46275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}